About Kent Teague

Kent Teague is a senior associate at Clayton Utz specialising in intellectual property dispute resolution, and a registered trade mark attorney. Kent has extensive experience in large and complex patent litigation, drawing on his relevant technical experience, including his Bachelor of Science majoring in Chemistry. Kent’s key clients include Novartis, Merck Sharp & Dohme, Sandoz, Alexion, Facebook/Meta, Instagram, and Optus. His recent work highlights include acting for Sandoz in the long-running Lexapro (escitalopram) litigation; acting for Novartis in infringement and validity proceedings concerning Gilenya (fingolimod); and acting for Merck Sharp & Dohme in competition proceedings against Bristol Myers Squibb.